Comparative study of safety and efficacy of imatinib mesylate therapy in pediatric and adult chronic myeloid leukemia

被引：0
|
作者：
Raizada, N. [1 ]
Sagar, T. [1 ]
Ramanan, S. [1 ]
机构：
[1] Canc Inst, Madras, Tamil Nadu, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
20016
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Comparative study for the efficacy, safety and quality of life in patients of chronic myeloid leukemia treated with Imatinib or Hydroxyurea
    Jain, Parveen
    Das, V. N. R.
    Ranjan, Alok
    Chaudhary, Rahul
    Pandey, Krishna
    JOURNAL OF RESEARCH IN PHARMACY PRACTICE, 2013, 2 (04) : 156 - 161
  • [22] Hypersensitivity pneumonitis related to imatinib mesylate therapy in a patient with chronic myeloid leukemia
    Kallel, Faten
    Kassar, Olfa
    Maaloul, Imen
    Charfi, Maha
    Ksouda, Kamilia
    Elloumi, Moez
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (07) : 1762 - 1765
  • [23] Kaposi's sarcoma associated with chronic myeloid leukemia and imatinib mesylate therapy
    D'Addona, Matteo
    Pezzullo, Luca
    Giudice, Valentina
    Serio, Bianca
    Baldi, Carlo
    Zeppa, Pio
    Selleri, Carmine
    CLINICAL CASE REPORTS, 2022, 10 (06):
  • [24] Molecular response of paediatric chronic myeloid leukemia (CML) with imatinib mesylate therapy
    Dhara, Atanu
    Mukhopadhyay, S.
    Das, S.
    Mukhopadhyay, A.
    PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 444 - 445
  • [25] Subdural hematomas during therapy with imatinib mesylate for chronic myeloid leukemia.
    Song, KW
    Al-Beirouiti, B
    Yee, K
    McCrae, J
    Messner, H
    Keating, A
    Lipton, J
    BLOOD, 2002, 100 (11) : 320B - 320B
  • [26] Granulocytic Sarcoma giant in chronic myeloid leukemia during imatinib mesylate therapy
    Cavalheiro, RDR
    Vicari, P
    Morselli, FM
    Ommati, LVM
    Rosa, FDF
    Oliveira, JSR
    AMERICAN JOURNAL OF HEMATOLOGY, 2006, 81 (01) : 76 - 77
  • [27] Μultiple myeloma developing after imatinib mesylate therapy for chronic myeloid leukemia
    A. Galanopoulos
    S. I. Papadhimitriou
    E. Kritikou-Griva
    M. Georgiakaki
    N. I. Anagnostopoulos
    Annals of Hematology, 2009, 88 : 281 - 282
  • [28] Results of imatinib mesylate therapy in chronic myeloid leukemia: Experience of a single center
    Pasa, S.
    Boyraz, T.
    Beyaz, C.
    Sayar, S.
    Atayan, Y.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 530 - 530
  • [29] The unfolding story of imatinib mesylate for chronic myeloid leukemia
    Goldman, John M.
    ONCOLOGY-NEW YORK, 2007, 21 (06): : 663 - 664
  • [30] Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia
    Kovitz, Craig
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    Abruzzo, Lynne V.
    Cortes, Jorge
    BLOOD, 2006, 108 (08) : 2811 - 2813
12345